COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

Clinical trial NCT04848467 · WITHDRAWN

Trial details

NCT number

NCT04848467

Sponsor

Bayer

Status

WITHDRAWN

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2021-10-01

Primary completion

2021-11-30

Enrollment

0

View on ClinicalTrials.gov